449 results on '"Sharaf, Barry"'
Search Results
2. Characteristics, Trends, and Outcomes of Intravascular Lithotripsy-Assisted Transfemoral Transcatheter Aortic Valve Replacement in United States.
3. Abstract 11607: In-Hospital and Readmission Outcomes With Percutaneous Balloon Mitral Valvuloplasty
4. Association between Red Blood Cell Transfusion and 30-day Readmission Following Transcatheter Aortic Valve Replacement
5. Comparison of Incidence, Predictors, and Outcomes of Early Infective Endocarditis after Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in the United States
6. C-83 | Characteristics, Trends, and Outcomes of Intravascular Lithotripsy-Assisted Transfemoral Transcatheter Aortic Valve Replacement In the United States: A Nationwide Analysis from the Vizient Clinical Database
7. OR7-1 | Use of Mechanical Circulatory Support for Cardiogenic Shock in Patients Undergoing Transcatheter Aortic Valve Replacement: A Nationwide Analysis from The Vizient Clinical Database
8. OR3-9 | Characteristics, Trends, and Outcomes of Intravascular Lithotripsy-Assisted Transfemoral Transcatheter Aortic Valve Replacement In the United States: A Nationwide Analysis from the Vizient Clinical Database
9. Outcomes Following Urgent/Emergent Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry
10. Premature atherosclerosis in premenopausal women: Does cytokine balance play a role?
11. Management strategies and possible risk factors for ventricular septal defects after transcatheter aortic valve replacement: Case series from a single center and review of literature
12. Migraine Headache and Long-Term Cardiovascular Outcomes: An Extended Follow-Up of the Women's Ischemia Syndrome Evaluation
13. THE ASSOCIATION OF PRE-TAVI HOSPITALIZATIONS ON THE SHORT-TERM OUTCOMES AFTER TAVI
14. Transcatheter Edge-to-Edge Repair of Mitral Valve Regurgitation: Closing the Gap to Broaden the Coverage
15. In-hospital and Readmission Outcomes With Percutaneous Balloon Mitral Valvuloplasty
16. Thirty-Day Readmissions After Transcatheter Aortic Valve Replacement in the United States: Insights From the Nationwide Readmissions Database
17. Transcatheter Aortic Valve Replacement in Special Populations.
18. Safety of Coronary Reactivity Testing in Women With No Obstructive Coronary Artery Disease: Results From the NHLBI-Sponsored WISE (Women's Ischemia Syndrome Evaluation) Study
19. DIET, ANGIOGRAPHIC CORONARY DISEASE, AND CARDIOVASCULAR OUTCOMES IN WOMEN
20. Sex‐related differences in the trends and outcomes of trans‐septal transcatheter mitral valve replacement: Insights from the National Readmissions Database
21. DISTAL IPSILATERAL PROTECTION ACCESS FOR MANTA CLOSURE DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: A NOVEL SOLUTION TO AN OLD PROBLEM
22. Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: An ancillary study of the National Heart, Lung, and Blood Institute–sponsored Womenʼs Ischemia Syndrome Evaluation
23. Does expanded artificial intelligence improve the prognostic value of myocardial perfusion imaging? A report from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE)
24. A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: Results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Womenʼs Ischemia Syndrome Evaluation (WISE)
25. Decisions Informed by Computing Entities (DICE) to improve prognostic value of myocardial perfusion imaging: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study
26. Gender-Based Outcomes in Percutaneous Coronary Intervention With Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic Registry)
27. Effectiveness of cardioprotective medication in women with suspected ischemic heart disease syndrome: the NHLBI-sponsored women's ischemia synrome evaluation (WISE) study
28. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: the NHLBI-Sponsored WISE Study
29. Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery disease
30. Exercise treadmill testing using a modified exercise protocol in women with suspected myocardial ischemia: findings from the National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)
31. Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women
32. Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: Findings from the National Heart, Lung, and Blood Institute–sponsored Womenʼs Ischemia Syndrome Evaluation (WISE) angiographic core laboratory
33. Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study
34. Accuracy of dipyridamole SPECT imaging in identifying individual coronary stenoses and multivessel disease in women versus men
35. Large brachial artery diameter is associated with angiographic coronary artery disease in women
36. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Womenʼs Ischemia Syndrome Evaluation (WISE)
37. Contrast Fractional Flow Reserve (cFFR) and Computed Tomography Fractional Flow Reserve (CT-FFR) Guidance for Percutaneous Coronary Intervention (PCI)
38. Trends and outcomes of red blood cell transfusion in patients undergoing transcatheter aortic valve replacement in the United States
39. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms
40. An Intravascular Ultrasound Analysis in Women Experiencing Chest Pain in the Absence of Obstructive Coronary Artery Disease: A Substudy from the National Heart, Lung and Blood Institute–Sponsored Womenʼs Ischemia Syndrome Evaluation (WISE)
41. Phytoestrogens and Lipoproteins in Women
42. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Womenʼs Ischaemia Syndrome Evaluation (WISE) study
43. Migraines, angiographic coronary artery disease and cardiovascular outcomes in women
44. Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: Results from the National Heart, Lung, and Blood Institute women's ischemia syndrome evaluation study
45. Validation of the accuracy of pretest and exercise test scores in women with a low prevalence of coronary disease: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study
46. B Vitamins and Restenosis after Coronary Angioplasty
47. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: Results from the NHLBI WISE study
48. Association Between Red Blood Cell Transfusion and Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement
49. Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD)
50. Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.